Monopolar Electrosurgery With Cochlear Implants

Nathan D. Cass,Nathan R. Lindquist,Marc L. Bennett,David S. Haynes
DOI: https://doi.org/10.1002/lary.30323
2022-08-05
Abstract:Monopolar electrosurgery is felt to be unsafe in the setting of indwelling cochlear implants (CIs). We describe 35 CI patients who experienced 63 unique monopolar electrosurgery events, none of which have resulted in known adverse effects. Objective To evaluate safety of monopolar electrosurgery (MES) in patients with cochlear implants (CIs) by reporting outcomes of a series of patients who underwent MES after CI. Study Design Retrospective case series. Setting Tertiary referral center. Patients Patients with indwelling CI subsequently undergoing surgery with operative note specifically detailing MES use. Main Outcome Measures Adverse outcomes in post‐operative audiology/otolaryngology documentation; speech recognition scores. Results Thirty‐five patients (10 with bilateral CI) experienced 63 unique MES exposure events, 85.7% below and 14.3% above the clavicle. No adverse events or decreased performance due to MES use were reported for any patient. Pre‐ and immediate postoperative speech recognition scores were not significantly different for patients using either consonant‐nucleus‐consonant (CNC; n = 23, 68%–66%, p = 0.80) or AzBio (n = 15, 82%–88%, p = 0.60). For individual CNC performance, 21 (91%) patients demonstrated stability, 1 improved >15%, and 1 declined >15%, although this patient had become a non‐user due to magnet issues and, after resolution of these issues, exceeded baseline pre‐operative score. For individual AzBio performance, 12 (80%) patients demonstrated stability, 3 improved >15%, and none declined >15%. Conclusions No adverse events resulted from MES use in CI patients. Given the increased prevalence and expansion of indications for CIs, and widespread utility of MES, we suggest clarification and improved guidance from device manufacturers regarding safety and use of MES for patients with these devices. We hope that data regarding electrosurgery exposure events will better inform clinician decision‐making with regards to relative benefits and risks for MES use for CI patients. Level of Evidence 4 Laryngoscope, 2022
medicine, research & experimental,otorhinolaryngology
What problem does this paper attempt to address?